Methyprylon

This classification denotes a sedative and hypnotic with the molecular formula C10H17NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier CUT48I42ON, chemically known as 3,3-diethyl-5-methylpiperidine-2,4-dione but generally known as methyprylon, which bears US NIH Compound Identifier 4162. European Medicines Agency schedules Methyprylon in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08879MIG. The term METHYPRYLON is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 13, No. 12, 1959, List 3). World Health Organization schedules methyprylon in its Anatomical Therapeutic Chemical (ATC) Classification. METHYPRYLON is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule methyprylon under HS 29337200 and SITC 51561. As of Q4 2014, METHYPRYLON remains the US FDA Preferred Term for this commodity. Methyprylon bears US NLM identifiers UMLS ID C0025840 and NCI Concept Code C66122. SMILES: CCC1(C(=O)C(CNC1=O)C)CC.